A Phase IIa, Randomized, Double-blind, Placebo Controlled, Parallel Group, Multi-center Trial to Evaluate the Efficacy and Safety of ONO-1110 in Patients With Fibromyalgia
Status: Recruiting
Location: See all (27) locations...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
To Evaluate the Efficacy and Safety of ONO-1110 in Patients with Fibromyalgia
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Japanese (both sexes)
• Outpatient
• Patients who are considered capable of understanding the study procedures and completing the pain diary and questionnaires appropriately by the investigator (sub-investigator)
• Patients who meet the American College of Rheumatology Fibromyalgia Criteria
Locations
Other Locations
Japan
Ai Sakura Clinic
RECRUITING
Fukuoka
Kyushu University Hospital
RECRUITING
Fukuoka
Kokorotoitami Clinic
RECRUITING
Kawasaki
Shirasawa Orthopedic Clinic
RECRUITING
Morioka
Aichi Medical University Hospital
RECRUITING
Nagakute
Kimura Clinic
RECRUITING
Nagoya
Medical Corporation Fujigaki Clinic
RECRUITING
Ōita
Japanese Red Cross Okayama Hospital
RECRUITING
Okayama
Miyashita Rheumatology Clinic
RECRUITING
Ōmura
Hayaishi Hospital
RECRUITING
Osaka
Morimoto Clinic
RECRUITING
Osaka
Sapporo City General Hospital
RECRUITING
Sapporo
Shizuoka Rehab Pain Clinic
RECRUITING
Shizuoka
Fukuwa Clinic
RECRUITING
Tokyo
Ginza Neurological Clinic
RECRUITING
Tokyo
Himenotomomi Clinic
RECRUITING
Tokyo
Ikebukuro Internal Medicine
RECRUITING
Tokyo
Juntendo Tokyo Koto Geriatric Medical Center
RECRUITING
Tokyo
Juntendo University Hospital
RECRUITING
Tokyo
Juntendo University Nerima Hospital
RECRUITING
Tokyo
Nihonbashi Medical
RECRUITING
Tokyo
Nishiogi Pain Clinic
RECRUITING
Tokyo
Sanno Hospital
RECRUITING
Tokyo
Tokyo-Eki Center-Building Clinic
RECRUITING
Tokyo
Yakushinkai Healthcare Association Kandasudacho Dermatology
RECRUITING
Tokyo
Women's Clinic Luna
RECRUITING
Yokohama
National Hospital Organization Shimoshizu National Hospital
RECRUITING
Yotsukaidō
Contact Information
Primary
North America Clinical Trial Support Desk
clinical_trial@ono-pharma.com
+18665877745(Toll-Free)
Backup
International Clinical Trial Support Desk
clinical_trial@ono-pharma.com
+17162141777(Standard)
Time Frame
Start Date: 2025-03-26
Estimated Completion Date: 2026-09
Participants
Target number of participants: 160
Treatments
Experimental: ONO-1110
ONO-1110 tablets once a day
Placebo_comparator: Placebo
Placebo tablets once daily
Related Therapeutic Areas
Sponsors
Leads: Ono Pharmaceutical Co. Ltd